Dr. Gabriel Angel Delgado, MD

Dr. Delgado practices at Novant Health Outpatient Infusion at Matthews - HOPD in Matthews, North Carolina.

Dr. Delgado's NPI, 1376511659, was assigned on March 10, 2006. Dr. Delgado holds North Carolina license 2014-00412.

Dr. Delgado's primary practice is Novant Health Outpatient Infusion at Matthews - HOPD, at 1500 Matthews Township Pkwy, Matthews, NC 28105.

Dr. Delgado's primary practice is Novant Health Outpatient Infusion at Matthews - HOPD in Matthews, North Carolina. Dr. Delgado is also affiliated with Novant Health Matthews Medical Center. The medical group on file is Novant Health Indian Land Primary Care. Dmand AI also links Dr. Delgado to 2 more hospitals, 9 medical groups and 6 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Delgado practices, 10 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Delgado's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Delgado is licensed in North Carolina.

CMS data shows 1,585 Medicare services from Dr. Delgado across 31 procedure codes in 2024, for 633 Medicare patients. Medicare paid $102,584 for them.

CMS counts 633 Medicare patients who saw Dr. Delgado in 2024. The largest group is 75 to 84, with 264 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Delgado's median patient age at 74, with 47% women.

In 2024, Dr. Delgado wrote 1,202 Medicare Part D claims for 255 patients. 80% of them were for generic drugs. CMS names the drug for 1,028 of them, across 26 drugs with 11 or more claims each, at $212,410 in total drug cost. In 2023, CMS named 1,036 claims across 26 drugs.

CMS counts 49 procedures of coronary angioplasty and stenting by Dr. Delgado, more than 83% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Delgado in 2011. Dr. Delgado's most frequent co-authors are Robert Michael Kirchner, MD and Ryan William Zuzek, MD.

Dmand AI links Dr. Delgado to 1 clinical trial. Conditions studied include Peripheral Arterial Disease and Peripheral Vascular Diseases.

CMS Open Payments shows 135 general payments to Dr. Delgado from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 44% of the total. Boston Scientific Corporation paid the most, $6,303. It also lists 1 research payment totaling $500 in 2020.